Breaking News Instant updates and real-time market news.

FUN

Cedar Fair

/

+

07:00
06/11/20
06/11
07:00
06/11/20
07:00

Cedar Fair price target raised to $44 from $34 at Stifel

Stifel analyst Steven Wieczynski raised the firm's price target on Cedar Fair to $44 from $34 and keeps a Buy rating on the shares following investor meetings at the firm's annual Cross Sector Insights Conference that have left him feeling better about recovery prospects. Management believes there should be significant pent-up demand as parks reopen, given "extensive survey work" within their active pass base, Wieczynski tells investors. As parks have announced firm opening dates, season pass sales have started to accelerate and management thinks there could be an elongated pass selling season for 2021, the analyst added.

FUN Cedar Fair
/

+

06/09/20 B. Riley FBR
Cedar Fair price target raised to $42 from $27 at B. Riley FBR
05/28/20
Fly Intel: Top five analyst initiations
05/28/20 Goldman Sachs
Cedar Fair initiated with a Buy at Goldman Sachs
05/21/20 Credit Suisse
Cedar Fair initiated with an Outperform at Credit Suisse

TODAY'S FREE FLY STORIES

Downgrade
Seanergy Marine downgraded to Hold from Buy at Maxim » 07:40
07/08/20
07/08
07:40
07/08/20
07:40
SHIP

Seanergy Marine

$2.00 /

-0.115 (-5.45%)

Maxim analyst Tate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHIP Seanergy Marine
$2.00 /

-0.115 (-5.45%)

SHIP Seanergy Marine
$2.00 /

-0.115 (-5.45%)

Hot Stocks
Kitov Pharmaceuticals to be granted patent for CM24 from EPO » 07:40
07/08/20
07/08
07:40
07/08/20
07:40
KTOV

Kitov Pharmaceuticals

$0.79 /

-0.085 (-9.77%)

, BMY

Bristol-Myers

$60.30 /

+0.09 (+0.15%)

Kitov Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTOV Kitov Pharmaceuticals
$0.79 /

-0.085 (-9.77%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

KTOV Kitov Pharmaceuticals
$0.79 /

-0.085 (-9.77%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

06/22/20 Morgan Stanley
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

Recommendations
BJ's Wholesale price target raised to $45 from $40 at Loop Capital » 07:39
07/08/20
07/08
07:39
07/08/20
07:39
BJ

BJ's Wholesale

$37.22 /

+0.285 (+0.77%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BJ BJ's Wholesale
$37.22 /

+0.285 (+0.77%)

BJ BJ's Wholesale
$37.22 /

+0.285 (+0.77%)

06/01/20 JPMorgan
Ulta Beauty removed from Analyst Focus List at JPMorgan
05/22/20 Loop Capital
BJ's Wholesale price target raised to $40 from $35 at Loop Capital
05/22/20 JPMorgan
JPMorgan boosts BJ's Wholesale target to $43, sees 'more room to run'
05/22/20 Baird
BJ's Wholesale price target raised to $40 from $32 at Baird
BJ BJ's Wholesale
$37.22 /

+0.285 (+0.77%)

  • 17
    Jan
BJ BJ's Wholesale
$37.22 /

+0.285 (+0.77%)

BJ BJ's Wholesale
$37.22 /

+0.285 (+0.77%)

BJ BJ's Wholesale
$37.22 /

+0.285 (+0.77%)

Recommendations
Walmart poised to lead in Digital Grocery, says Baird » 07:38
07/08/20
07/08
07:38
07/08/20
07:38
WMT

Walmart

$126.97 /

+8.08 (+6.80%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$126.97 /

+8.08 (+6.80%)

WMT Walmart
$126.97 /

+8.08 (+6.80%)

07:17 Today Deutsche Bank
Walmart subscription business a 'big plus,' says Deutsche Bank
06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
06/22/20 Guggenheim
Walmart price target raised to $145 from $140 at Guggenheim
06/22/20 UBS
Walmart upgraded to Buy from Neutral at UBS
WMT Walmart
$126.97 /

+8.08 (+6.80%)

WMT Walmart
$126.97 /

+8.08 (+6.80%)

WMT Walmart
$126.97 /

+8.08 (+6.80%)

WMT Walmart
$126.97 /

+8.08 (+6.80%)

Hot Stocks
Biogen completes aducanumab BLA submission to FDA » 07:37
07/08/20
07/08
07:37
07/08/20
07:37
BIIB

Biogen

$268.18 /

-1.37 (-0.51%)

Biogen announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$268.18 /

-1.37 (-0.51%)

BIIB Biogen
$268.18 /

-1.37 (-0.51%)

07/07/20 SunTrust
Sangamo initiated with a Buy at SunTrust
06/22/20 RBC Capital
Biogen price target lowered to $273 from $303 at RBC Capital
06/22/20 Barclays
Barclays downgrades Biogen to Equal Weight on 'mounting uncertainties'
06/22/20 Barclays
Biogen downgraded to Equal Weight from Overweight at Barclays
BIIB Biogen
$268.18 /

-1.37 (-0.51%)

BIIB Biogen
$268.18 /

-1.37 (-0.51%)

BIIB Biogen
$268.18 /

-1.37 (-0.51%)

BIIB Biogen
$268.18 /

-1.37 (-0.51%)

Hot Stocks
Abeona Therapeutics restarts patient enrollment in VIITAL study of EB-101 » 07:35
07/08/20
07/08
07:35
07/08/20
07:35
ABEO

Abeona Therapeutics

$3.40 /

+0.285 (+9.16%)

Abeona Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABEO Abeona Therapeutics
$3.40 /

+0.285 (+9.16%)

ABEO Abeona Therapeutics
$3.40 /

+0.285 (+9.16%)

06/05/20 Cantor Fitzgerald
Abeona could trade higher on Lysogene clinical hold, says Cantor Fitzgerald
05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
ABEO Abeona Therapeutics
$3.40 /

+0.285 (+9.16%)

  • 20
    Dec
General news
Treasury Market Outlook: trading was choppy overnight » 07:35
07/08/20
07/08
07:35
07/08/20
07:35

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Unusual call flow in option market yesterday » 07:35
07/08/20
07/08
07:35
07/08/20
07:35
DIS

Disney

$113.61 /

-0.86 (-0.75%)

, ET

Energy Transfer LP

$6.31 /

+0.065 (+1.04%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$113.61 /

-0.86 (-0.75%)

ET Energy Transfer LP
$6.31 /

+0.065 (+1.04%)

DIS Disney
$113.61 /

-0.86 (-0.75%)

07:13 Today Guggenheim
Disney price target raised to $123 from $115 at Guggenheim
06/24/20 Morgan Stanley
Morgan Stanley says time might be right for Disney to move ESPN to streaming
06/19/20 Wells Fargo
Disney price target raised to $118 from $107 at Wells Fargo
06/15/20 BofA
BofA boosts Disney target to $146, sees 'compelling' entry point
ET Energy Transfer LP
$6.31 /

+0.065 (+1.04%)

06/22/20 Citi
Energy Transfer LP price target lowered to $10 from $18 at Citi
06/09/20
Fly Intel: Top five analyst upgrades
06/09/20 BMO Capital
Energy Transfer LP upgraded to Outperform from Market Perform at BMO Capital
05/13/20 Bernstein
Energy Transfer LP price target lowered to $12 from $22 at Bernstein
DIS Disney
$113.61 /

-0.86 (-0.75%)

ET Energy Transfer LP
$6.31 /

+0.065 (+1.04%)

DIS Disney
$113.61 /

-0.86 (-0.75%)

ET Energy Transfer LP
$6.31 /

+0.065 (+1.04%)

DIS Disney
$113.61 /

-0.86 (-0.75%)

ET Energy Transfer LP
$6.31 /

+0.065 (+1.04%)

DIS Disney
$113.61 /

-0.86 (-0.75%)

ET Energy Transfer LP
$6.31 /

+0.065 (+1.04%)

Hot Stocks
Discover signs network alliance agreement with Saudi Payments » 07:34
07/08/20
07/08
07:34
07/08/20
07:34
DFS

Discover

$48.12 /

-2.49 (-4.92%)

Discover and Saudi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DFS Discover
$48.12 /

-2.49 (-4.92%)

DFS Discover
$48.12 /

-2.49 (-4.92%)

06/22/20 UBS
Discover upgraded to Buy from Neutral at UBS
06/22/20 UBS
Discover upgraded to Buy from Neutral at UBS
06/03/20 RBC Capital
Discover price target raised to $61 from $42 at RBC Capital
05/14/20 BMO Capital
BMO Capital upgrades Discover to Outperform with stock down over 50% this year
DFS Discover
$48.12 /

-2.49 (-4.92%)

DFS Discover
$48.12 /

-2.49 (-4.92%)

DFS Discover
$48.12 /

-2.49 (-4.92%)

DFS Discover
$48.12 /

-2.49 (-4.92%)

Downgrade
Morgan Stanley downgrades Transocean to Equal Weight on offshore drilling view » 07:34
07/08/20
07/08
07:34
07/08/20
07:34
RIG

Transocean

$1.99 /

+0.03 (+1.53%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIG Transocean
$1.99 /

+0.03 (+1.53%)

RIG Transocean
$1.99 /

+0.03 (+1.53%)

05:30 Today Morgan Stanley
Transocean downgraded to Equal Weight from Overweight at Morgan Stanley
07/02/20 Evercore ISI
Transocean secures contract for 20k PSI drillship, says Evercore ISI
06/15/20
Fly Intel: Top five analyst downgrades
06/15/20 Clarksons Platou
Transocean downgraded to Neutral from Buy at Clarksons Platou
RIG Transocean
$1.99 /

+0.03 (+1.53%)

RIG Transocean
$1.99 /

+0.03 (+1.53%)

RIG Transocean
$1.99 /

+0.03 (+1.53%)

RIG Transocean
$1.99 /

+0.03 (+1.53%)

Syndicate
HealthEquity files to sell $250M in common stock » 07:33
07/08/20
07/08
07:33
07/08/20
07:33
HQY

HealthEquity

$58.20 /

-2.41 (-3.98%)

Wells Fargo Securities,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HQY HealthEquity
$58.20 /

-2.41 (-3.98%)

HQY HealthEquity
$58.20 /

-2.41 (-3.98%)

06/03/20 Barrington
HealthEquity earnings selloff a buying opportunity, says Barrington
06/03/20 Cantor Fitzgerald
HealthEquity price target lowered to $70 from $80 at Cantor Fitzgerald
04/14/20 Guggenheim
Guggenheim starts HealthEquity at Buy with $56 price target
04/14/20 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
HQY HealthEquity
$58.20 /

-2.41 (-3.98%)

  • 10
    Jul
HQY HealthEquity
$58.20 /

-2.41 (-3.98%)

Earnings
Nephros reports preliminary Q2 revenue $1.6M, consensus $2.24M » 07:32
07/08/20
07/08
07:32
07/08/20
07:32
NEPH

Nephros

$8.05 /

-0.02 (-0.25%)

Nephros ended the quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEPH Nephros
$8.05 /

-0.02 (-0.25%)

NEPH Nephros
$8.05 /

-0.02 (-0.25%)

01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
10/24/19 Benchmark
Nephros initiated with a Speculative Buy at Benchmark
10/04/19 Maxim
Nephros initiated with a Buy rating at Maxim
NEPH Nephros
$8.05 /

-0.02 (-0.25%)

  • 31
    Jan
Hot Stocks
Palatin reinitiates enrollment of Phase 2 study with PL9643 for dry eye disease » 07:32
07/08/20
07/08
07:32
07/08/20
07:32
PTN

Palatin

$0.52 /

+0.0106 (+2.10%)

Palatin Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PTN Palatin
$0.52 /

+0.0106 (+2.10%)

PTN Palatin
$0.52 /

+0.0106 (+2.10%)

01/10/20 H.C. Wainwright
Palatin price target lowered to $2 from $7.50 at H.C. Wainwright
PTN Palatin
$0.52 /

+0.0106 (+2.10%)

Hot Stocks
Axon says Baltimore Police Department deploying Axon Records » 07:31
07/08/20
07/08
07:31
07/08/20
07:31
AAXN

Axon

$96.06 /

-3.54 (-3.55%)

Axon announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAXN Axon
$96.06 /

-3.54 (-3.55%)

AAXN Axon
$96.06 /

-3.54 (-3.55%)

06/12/20 Baird
Axon price target raised to $112 from $90 at Baird
06/10/20 JPMorgan
Axon price target raised to $120 from $90 at JPMorgan
05/18/20 Imperial Capital
Axon price target raised to $82 from $78 at Imperial Capital
03/02/20 Imperial Capital
Axon downgraded to In-Line from Outperform at Imperial Capital
AAXN Axon
$96.06 /

-3.54 (-3.55%)

  • 17
    Jun
AAXN Axon
$96.06 /

-3.54 (-3.55%)

AAXN Axon
$96.06 /

-3.54 (-3.55%)

Recommendations
Postmates stronger fit for Uber, less market share than GrubHub, says Wedbush » 07:30
07/08/20
07/08
07:30
07/08/20
07:30
UBER

Uber

$32.80 /

+0.29 (+0.89%)

, GRUB

GrubHub

$71.11 /

-1.955 (-2.68%)

, DASH

DoorDash

$0.00 /

+ (+0.00%)

Commenting on Uber's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$32.80 /

+0.29 (+0.89%)

GRUB GrubHub
$71.11 /

-1.955 (-2.68%)

DASH DoorDash
$0.00 /

+ (+0.00%)

UBER Uber
$32.80 /

+0.29 (+0.89%)

07/07/20 KeyBanc
Uber acquisition of Postmates helps drive market rationalization, says KeyBanc
07/06/20 RBC Capital
Uber price target lowered to $45 from $52 at RBC Capital
07/06/20 Benchmark
Waitr Holdings price target raised to $5 from $4 at Benchmark
07/06/20 Wedbush
Uber's acquisition of Postmates 'a smart strategic move,' says Wedbush
GRUB GrubHub
$71.11 /

-1.955 (-2.68%)

07/06/20 Wedbush
Uber's acquisition of Postmates 'a smart strategic move,' says Wedbush
07/01/20 Northcoast
Chipotle's GrubHub deal should drive SSS growth in 2H, says Northcoast
06/30/20 SunTrust
Uber shouldn't face regulatory issues if it buys Postmates, says Suntrust
06/25/20 Canaccord
Canaccord downgraded GrubHub after announced merger
DASH DoorDash
$0.00 /

+ (+0.00%)

07/06/20 Wedbush
Uber's acquisition of Postmates 'a smart strategic move,' says Wedbush
UBER Uber
$32.80 /

+0.29 (+0.89%)

GRUB GrubHub
$71.11 /

-1.955 (-2.68%)

  • 11
    Feb
  • 07
    Nov
  • 06
    Nov
UBER Uber
$32.80 /

+0.29 (+0.89%)

GRUB GrubHub
$71.11 /

-1.955 (-2.68%)

UBER Uber
$32.80 /

+0.29 (+0.89%)

GRUB GrubHub
$71.11 /

-1.955 (-2.68%)

DASH DoorDash
$0.00 /

+ (+0.00%)

UBER Uber
$32.80 /

+0.29 (+0.89%)

GRUB GrubHub
$71.11 /

-1.955 (-2.68%)

Recommendations
Livongo Health price target raised to $120 from $70 at Needham » 07:30
07/08/20
07/08
07:30
07/08/20
07:30
LVGO

Livongo Health

$93.76 /

+16.19 (+20.87%)

Needham analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

  • 12
    Dec
  • 25
    Jul
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

Downgrade
Morgan Stanley downgrades Vertex on valuation, ups price target to $300 » 07:30
07/08/20
07/08
07:30
07/08/20
07:30
VRTX

Vertex

$298.73 /

+7.47 (+2.56%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex
$298.73 /

+7.47 (+2.56%)

VRTX Vertex
$298.73 /

+7.47 (+2.56%)

05:37 Today Morgan Stanley
Vertex downgraded to Equal Weight from Overweight at Morgan Stanley
07/02/20 Goldman Sachs
Vertex price target raised to $330 from $290 at Goldman Sachs
07/01/20 Jefferies
Vertex reimbursement in England 'a remarkable positive,' says Jefferies
06/26/20 Piper Sandler
Piper says EU approval can help drive next leg of CF growth at Vertex
VRTX Vertex
$298.73 /

+7.47 (+2.56%)

VRTX Vertex
$298.73 /

+7.47 (+2.56%)

VRTX Vertex
$298.73 /

+7.47 (+2.56%)

Conference/Events
Morgan Stanley QIS analyst/industry conference call » 07:25
07/08/20
07/08
07:25
07/08/20
07:25

Global Head of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Morgan Stanley software analysts to hold a webinar » 07:25
07/08/20
07/08
07:25
07/08/20
07:25

Software Analysts Wood…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Morgan Stanley chemicals analysts to hold analyst/industry conference call » 07:25
07/08/20
07/08
07:25
07/08/20
07:25

Saudi Arabia Chemicals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
'Nervous' Deutsche Bank raises Apple price target to $400 from $380 » 07:24
07/08/20
07/08
07:24
07/08/20
07:24
AAPL

Apple

$372.67 /

-1.19 (-0.32%)

Deutsche Bank analyst…

Deutsche Bank analyst Jeriel Ong raised the firm's price target on Apple to $400 from $380 and keeps a Buy rating on the shares. The stock closed Tuesday down $1.16 to $372.69. "It seems that AAPL is reaching all-time highs every week, and that has us nervous," Ong tells investors in a research note. Shares of Apple now stand 15% higher than their pre-COVID peak of $325 and 66% higher than their COVID lows of $225, says the analyst. Ong believes that with such volatility in the largest company in the world, Apple's "quick rise has some investors a bit anxious." However, the analyst feels comfortable that Apple should continue to offer upside for investors. Ong raised earnings and revenue estimates 2%/3% and 3%/5% for 2020 and 2021, respectively.

ShowHide Related Items >><<
AAPL Apple
$372.67 /

-1.19 (-0.32%)

AAPL Apple
$372.67 /

-1.19 (-0.32%)

07/07/20 Raymond James
Apple price target raised to $400 from $340 at Raymond James
07/06/20 Loop Capital
Apple's build plan update negates speculation of cut, says Loop Capital
06/26/20 Evercore ISI
Evercore upgrades Broadcom to Outperform, sees Apple sales driving upside
06/25/20 Wedbush
Wedbush boosts Apple target to $425, sees $2 trillion valuation in 2021
AAPL Apple
$372.67 /

-1.19 (-0.32%)

AAPL Apple
$372.67 /

-1.19 (-0.32%)

AAPL Apple
$372.67 /

-1.19 (-0.32%)

AAPL Apple
$372.67 /

-1.19 (-0.32%)

AAPL Apple
$372.67 /

-1.19 (-0.32%)

Downgrade
Imperial Oil downgraded to Equal Weight on valuation at Morgan Stanley » 07:22
07/08/20
07/08
07:22
07/08/20
07:22
IMO

Imperial Oil

$15.89 /

-0.33 (-2.03%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMO Imperial Oil
$15.89 /

-0.33 (-2.03%)

06:10 Today Morgan Stanley
Imperial Oil downgraded to Equal Weight from Overweight at Morgan Stanley
05/12/20 RBC Capital
Imperial Oil price target raised to C$23 from C$21 at RBC Capital
05/04/20 BMO Capital
Imperial Oil price target raised to C$23 from C$21 at BMO Capital
04/29/20 Citi
Imperial Oil upgraded to Neutral from Sell at Citi
Upgrade
Maximus upgraded to Strong Buy from Market Perform at Raymond James » 07:21
07/08/20
07/08
07:21
07/08/20
07:21
MMS

Maximus

$71.02 /

+0.885 (+1.26%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMS Maximus
$71.02 /

+0.885 (+1.26%)

MMS Maximus
$71.02 /

+0.885 (+1.26%)

05:20 Today Raymond James
Maximus upgraded to Strong Buy from Market Perform at Raymond James
06/24/20 KeyBanc
Maximus upgraded to Overweight from Sector Weight at KeyBanc
06/23/20 KeyBanc
Maximus upgraded to Overweight from Sector Weight at KeyBanc
08/09/19
Fly Intel: Top five analyst downgrades
MMS Maximus
$71.02 /

+0.885 (+1.26%)

MMS Maximus
$71.02 /

+0.885 (+1.26%)

Downgrade
CACI downgraded to Market Perform from Outperform at Raymond James » 07:20
07/08/20
07/08
07:20
07/08/20
07:20
CACI

CACI

$204.96 /

-5.88 (-2.79%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CACI CACI
$204.96 /

-5.88 (-2.79%)

CACI CACI
$204.96 /

-5.88 (-2.79%)

05:20 Today Raymond James
CACI downgraded to Market Perform from Outperform at Raymond James
06/12/20 William Blair
William Blair sees near-term takeover of Perspecta as unlikely despite Jana news
05/04/20 Wells Fargo
Leidos price target raised to $114 from $105 at Wells Fargo
04/20/20 Citi
CACI upgraded to Buy from Neutral at Citi
CACI CACI
$204.96 /

-5.88 (-2.79%)

CACI CACI
$204.96 /

-5.88 (-2.79%)

CACI CACI
$204.96 /

-5.88 (-2.79%)

Recommendations
Air Products price target raised to $300 from $250 at Deutsche Bank » 07:20
07/08/20
07/08
07:20
07/08/20
07:20
APD

Air Products

$265.12 /

+16.435 (+6.61%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APD Air Products
$265.12 /

+16.435 (+6.61%)

APD Air Products
$265.12 /

+16.435 (+6.61%)

07:10 Today SunTrust
Air Products price target raised to $295 from $265 at SunTrust
06/16/20
Fly Intel: Top five analyst downgrades
06/16/20 HSBC
Air Products downgraded to Hold on cyclicality, valuation at HSBC
06/16/20 HSBC
Air Products downgraded to Hold from Buy at HSBC
APD Air Products
$265.12 /

+16.435 (+6.61%)

APD Air Products
$265.12 /

+16.435 (+6.61%)

APD Air Products
$265.12 /

+16.435 (+6.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.